Phase 3 Asthma Trial, Recruiting

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• Children aged between 2 and 17 years old (before their 18th birthday).
• Children who have been diagnosed with asthma or an asthma-like condition by a doctor, including an emergency department doctor.
• Children whose asthma is considered moderate to severe after already receiving three rounds of inhaled breathing treatments (salbutamol and ipratropium) in the emergency department, based on a specific symptom score of 5 or higher.

Who may not be able to join:

• Children who have already received intravenous magnesium (a medication given through a drip) within the 24 hours before arriving at the emergency department.
• Children who need immediate breathing support on arrival, such as a special high-flow oxygen mask, a breathing machine, or a breathing tube inserted into the airway. (Note: basic supplemental oxygen on its own does not disqualify a child.)
• Children known to have kidney disease, a long-term lung condition, a neurological condition, a heart condition, or another serious ongoing illness.
• Children with a known allergy or sensitivity to magnesium sulfate.
• Children who have previously taken part in this trial.
• Families where neither English nor French is understood well enough to give informed consent.
• Families without access to a phone or email, or who would be otherwise unavailable for follow-up contact after the visit.

Important: Always verify eligibility with the trial site directly before applying.